Cancer continues to be a big area of investor interest and Surface Oncology now aims to tap into that with
Category Archives: Uncategorized
March 28 Webinar: Emerging Trends in Academic & Industry Collaboration
Novel collaborations between industry and academia are driving the commercialization of the next generation of biomedical cures. BIO One-on-One PartneringTM,
Auris Health’s Surgical Robot Gets FDA Green Light for Lung Cancer
Auris Health is now the latest surgical robot company with the go-ahead to enter the U.S. market. The Redwood City,
Flashback Friday: BIO ’97 Rodeo & Ranch Party
This post is part of BIO’s yearlong, bi-weekly series called Flashback Friday, highlighting newsletter stories from BIO’s past. To learn
Research Headlines – Novel computational models to predict and prevent the next financial crisis
[Source: Research & Innovation] EU-funded researchers have developed novel mathematical models and tools to better prepare financial markets for the
Salim Yazji Joins PMV Pharma as Chief Medical Officer
PMV Pharmaceuticals has appointed Salim Yazji to serve as chief medical officer of the Cranbury, NJ, cancer drug developer. Yazji
San Antonio Bioscience and Technology Development Group Replaces CEO
San Antonio – The first CEO of VelocityTX, an emerging technology and startup resource center in San Antonio, has left the
Research Headlines – Promoting inclusion by rethinking Europe’s heritage
[Source: Research & Innovation] At a time when consensus on Europe’s past is breaking down, EU-funded researchers are rethinking the
At Opioid Hearing, BIO Exec Proposes Ways to Boost Pain Drug Development
After months of meetings and Congressional hearings on the unrelenting opioid addiction crisis, Congress has finally responded, with 25 bills
Highlighting History: Hong Kong’s New Listing Regime
Recent announcements that the Hong Kong Stock Exchange (HKEX) plans to allow the listing of pre-revenue biotech companies onto it’s